Diagnostic value of serum tumor markers for adnexal masses

Milan Terzic, Jelena Dotlic, Ivana Likic, Branka Nikolic, Natasa Brndusic, Igor Pilic, Jovan Bila, Sanja Maricic, Nebojsa Arsenovic

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Objective: The study aim was to investigate the diagnostic value of measuring preoperative serum tumor markers in patients with adnexal masses. Methods: The study included all (358) consecutive patients treated for adnexal tumors at the Clinic of Obstetrics and Gynecology, Clinical Center of Serbia during 12 months. Tumor-marker levels (Ca 125, CEA, HE 4, Ca 19.9 and Ca 15.3) obtained from all women on admission were compared with histopathological findings in cases in which tumors were removed. Results: Women with malignant tumors had the highest levels of Ca 125, CEA and HE 4 (p<0.01). Mucinous adenocarcinoma produced the highest amounts of Ca 19.9 and CEA. Ca 15.3 was the highest in women with endometrioid carcinoma. There were no significant differences in the levels of all serum tumor markers between women with benign and borderline tumors (p>0.05). Malignant forms of tumors were well indicated by Ca 125, HE 4 and Ca 15.3 levels. The combination of Ca 125 and HE 4 resulted in the highest sensitivity, specificity, and positive or negative predictive value (91.04%, 87.6%, 67.9%, 77.2%, respectively). Conclusions: Blood levels of tumor markers can be effective? predictors of the nature of adnexal masses. For the most precise evaluation, a combination of serum tumor markers should be used.

Original languageEnglish
Pages (from-to)417-423
Number of pages7
JournalCentral European Journal of Medicine
Volume9
Issue number3
DOIs
Publication statusPublished - Jan 1 2014

Fingerprint

Tumor Biomarkers
Biomarkers
Neoplasms
Serbia
Gynecology
Obstetrics
Sensitivity and Specificity

Keywords

  • Adnexal masses
  • Preoperative evaluation
  • Tumor markers

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Terzic, M., Dotlic, J., Likic, I., Nikolic, B., Brndusic, N., Pilic, I., ... Arsenovic, N. (2014). Diagnostic value of serum tumor markers for adnexal masses. Central European Journal of Medicine, 9(3), 417-423. https://doi.org/10.2478/s11536-013-0234-x

Diagnostic value of serum tumor markers for adnexal masses. / Terzic, Milan; Dotlic, Jelena; Likic, Ivana; Nikolic, Branka; Brndusic, Natasa; Pilic, Igor; Bila, Jovan; Maricic, Sanja; Arsenovic, Nebojsa.

In: Central European Journal of Medicine, Vol. 9, No. 3, 01.01.2014, p. 417-423.

Research output: Contribution to journalArticle

Terzic, M, Dotlic, J, Likic, I, Nikolic, B, Brndusic, N, Pilic, I, Bila, J, Maricic, S & Arsenovic, N 2014, 'Diagnostic value of serum tumor markers for adnexal masses', Central European Journal of Medicine, vol. 9, no. 3, pp. 417-423. https://doi.org/10.2478/s11536-013-0234-x
Terzic, Milan ; Dotlic, Jelena ; Likic, Ivana ; Nikolic, Branka ; Brndusic, Natasa ; Pilic, Igor ; Bila, Jovan ; Maricic, Sanja ; Arsenovic, Nebojsa. / Diagnostic value of serum tumor markers for adnexal masses. In: Central European Journal of Medicine. 2014 ; Vol. 9, No. 3. pp. 417-423.
@article{aec7d480ed8e49cfa2dbc759b5fc7d1b,
title = "Diagnostic value of serum tumor markers for adnexal masses",
abstract = "Objective: The study aim was to investigate the diagnostic value of measuring preoperative serum tumor markers in patients with adnexal masses. Methods: The study included all (358) consecutive patients treated for adnexal tumors at the Clinic of Obstetrics and Gynecology, Clinical Center of Serbia during 12 months. Tumor-marker levels (Ca 125, CEA, HE 4, Ca 19.9 and Ca 15.3) obtained from all women on admission were compared with histopathological findings in cases in which tumors were removed. Results: Women with malignant tumors had the highest levels of Ca 125, CEA and HE 4 (p<0.01). Mucinous adenocarcinoma produced the highest amounts of Ca 19.9 and CEA. Ca 15.3 was the highest in women with endometrioid carcinoma. There were no significant differences in the levels of all serum tumor markers between women with benign and borderline tumors (p>0.05). Malignant forms of tumors were well indicated by Ca 125, HE 4 and Ca 15.3 levels. The combination of Ca 125 and HE 4 resulted in the highest sensitivity, specificity, and positive or negative predictive value (91.04{\%}, 87.6{\%}, 67.9{\%}, 77.2{\%}, respectively). Conclusions: Blood levels of tumor markers can be effective? predictors of the nature of adnexal masses. For the most precise evaluation, a combination of serum tumor markers should be used.",
keywords = "Adnexal masses, Preoperative evaluation, Tumor markers",
author = "Milan Terzic and Jelena Dotlic and Ivana Likic and Branka Nikolic and Natasa Brndusic and Igor Pilic and Jovan Bila and Sanja Maricic and Nebojsa Arsenovic",
year = "2014",
month = "1",
day = "1",
doi = "10.2478/s11536-013-0234-x",
language = "English",
volume = "9",
pages = "417--423",
journal = "Central European Journal of Medicine",
issn = "1895-1058",
publisher = "Springer Verlag",
number = "3",

}

TY - JOUR

T1 - Diagnostic value of serum tumor markers for adnexal masses

AU - Terzic, Milan

AU - Dotlic, Jelena

AU - Likic, Ivana

AU - Nikolic, Branka

AU - Brndusic, Natasa

AU - Pilic, Igor

AU - Bila, Jovan

AU - Maricic, Sanja

AU - Arsenovic, Nebojsa

PY - 2014/1/1

Y1 - 2014/1/1

N2 - Objective: The study aim was to investigate the diagnostic value of measuring preoperative serum tumor markers in patients with adnexal masses. Methods: The study included all (358) consecutive patients treated for adnexal tumors at the Clinic of Obstetrics and Gynecology, Clinical Center of Serbia during 12 months. Tumor-marker levels (Ca 125, CEA, HE 4, Ca 19.9 and Ca 15.3) obtained from all women on admission were compared with histopathological findings in cases in which tumors were removed. Results: Women with malignant tumors had the highest levels of Ca 125, CEA and HE 4 (p<0.01). Mucinous adenocarcinoma produced the highest amounts of Ca 19.9 and CEA. Ca 15.3 was the highest in women with endometrioid carcinoma. There were no significant differences in the levels of all serum tumor markers between women with benign and borderline tumors (p>0.05). Malignant forms of tumors were well indicated by Ca 125, HE 4 and Ca 15.3 levels. The combination of Ca 125 and HE 4 resulted in the highest sensitivity, specificity, and positive or negative predictive value (91.04%, 87.6%, 67.9%, 77.2%, respectively). Conclusions: Blood levels of tumor markers can be effective? predictors of the nature of adnexal masses. For the most precise evaluation, a combination of serum tumor markers should be used.

AB - Objective: The study aim was to investigate the diagnostic value of measuring preoperative serum tumor markers in patients with adnexal masses. Methods: The study included all (358) consecutive patients treated for adnexal tumors at the Clinic of Obstetrics and Gynecology, Clinical Center of Serbia during 12 months. Tumor-marker levels (Ca 125, CEA, HE 4, Ca 19.9 and Ca 15.3) obtained from all women on admission were compared with histopathological findings in cases in which tumors were removed. Results: Women with malignant tumors had the highest levels of Ca 125, CEA and HE 4 (p<0.01). Mucinous adenocarcinoma produced the highest amounts of Ca 19.9 and CEA. Ca 15.3 was the highest in women with endometrioid carcinoma. There were no significant differences in the levels of all serum tumor markers between women with benign and borderline tumors (p>0.05). Malignant forms of tumors were well indicated by Ca 125, HE 4 and Ca 15.3 levels. The combination of Ca 125 and HE 4 resulted in the highest sensitivity, specificity, and positive or negative predictive value (91.04%, 87.6%, 67.9%, 77.2%, respectively). Conclusions: Blood levels of tumor markers can be effective? predictors of the nature of adnexal masses. For the most precise evaluation, a combination of serum tumor markers should be used.

KW - Adnexal masses

KW - Preoperative evaluation

KW - Tumor markers

UR - http://www.scopus.com/inward/record.url?scp=84904110440&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84904110440&partnerID=8YFLogxK

U2 - 10.2478/s11536-013-0234-x

DO - 10.2478/s11536-013-0234-x

M3 - Article

AN - SCOPUS:84904110440

VL - 9

SP - 417

EP - 423

JO - Central European Journal of Medicine

JF - Central European Journal of Medicine

SN - 1895-1058

IS - 3

ER -